International Conference on Addiction Medicine, Mental Health and Psychiatry 2026

The International Conference on Addiction Medicine, Mental Health and Psychiatry is set to take place from March 23–25, 2026, in Singapore and Online, bringing together global leaders, researchers, clinicians, psychiatrists, psychologists, and mental health professionals.

This premier international event will focus on the latest research, innovative treatment approaches, policy developments, and interdisciplinary strategies in addiction medicine and psychiatric care.

🔬 Conference Highlights

• Advances in Addiction Treatment & Recovery

• Psychiatry & Behavioral Health Innovations

• Trauma-Informed Care & Neuroscience

• Mental Health Policy & Global Perspectives

• Integrative & Evidence-Based Therapies

• Emerging Research in Psychopharmacology

Whether you are a researcher, clinician, academic, or healthcare professional, this conference provides a global platform to exchange ideas, present research, and collaborate on solutions to today's mental health challenges.

🌐 Website: https://addiction.miconferences.com/
🧬 Submit Abstract: https://addiction.miconferences.com/abstract-submission
📝 Register Now: https://addiction.miconferences.com/register

Join us in shaping the future of addiction medicine and mental health care.

#AddictionMedicine #MentalHealthConference #Psychiatry2026 #AddictionRecovery #MentalHealthMatters #GlobalHealth #SingaporeConference #PsychiatryResearch #HealthcareInnovation

From Connection to Survival: A Topography of Our Survival System

Presenter: Mario C Salvador (ALECES, Spain)
Presentation Type: Oral Presentation (Virtual)
Title: From Connection to Survival, a topography of our survival system

---

🔬 Presentation Highlights

∙ Theoretical Framework: A trauma-informed methodology grounded in Polyvagal Theory — exploring the shift from connection to survival.
∙ Core Concept: How psychological defenses are organized when social connection fails or becomes harmful.
∙ Topographical Model:

• Upper Level: Social masks and introjects — learned defenses that preserve attachment at the cost of authenticity.

• Middle Level: Archeopsychic defenses — extreme, phobic mechanisms that suppress vulnerability and foster mistrust.

• Lower Level: Exiled and wounded parts of the self, excluded from both internal and relational life.
  ∙ Therapeutic Relationship: Emphasizes the healing power of a safe, reliable therapeutic bond to regulate the nervous system.
  ∙ Compassionate Inner Observer: Integration of self-compassionate mindfulness as a transformative dimension of healing.
  ∙ Clinical Application: Guides therapists in honoring defensive structures while facilitating trauma processing.
  ∙ Outcome: Restoration of compassionate inner connection — activating the brain-body’s self-healing capacity.

---

👨‍🏫 About the Speaker

Mario C Salvador is a psychologist and clinical psychology specialist with over 40 years of experience.

∙ Co-Director of ALECES – Institute of Integrative Trauma Psychotherapy (Spain).
∙ President of the Iberian Association of Brainspotting.
∙ Founder of the Ibero-American Association of Psychotrauma (AIBAPT).
∙ International trainer, lecturer, and trauma specialist.
∙ Author of five influential books:

• Beyond the Self: Healing Emotional Trauma and Brainspotting (2016, 2022)

• Who Am I? From Dissociation to Integration (2022)

• The Two Faces of Nina (2024)

• Our Internal Citadel (2025)

• Co-author of The Power of Brainspotting (2018)

His work bridges neuroscience, trauma therapy, attachment theory, and compassionate psychotherapy practices.

---

🌍 Join the Conference

Event: International Conference on Addiction Medicine, Mental Health and Psychiatry
📅 March 23–25, 2026
📍 Singapore & Online

🌐 Website: https://addiction.miconferences.com/
🧬 Submit Abstract: https://addiction.miconferences.com/abstract-submission
📝 Register Now: https://addiction.miconferences.com/register

Be part of global discussions on addiction medicine, trauma healing, psychiatry innovations, and mental health advancements.

#AddictionMedicine #MentalHealthMatters #PsychiatryConference #TraumaHealing #PolyvagalTheory #Brainspotting #AddictionResearch #Psychotherapy #ClinicalPsychology #Neuroscience #MentalHealthProfessionals #ICAMP2026 #SingaporeConference #GlobalPsychiatry #TherapeuticInnovation #CompassionInTherapy

Poetry Therapy (PT): A Promising Frontier for Addiction Treatment and Resilience Building

Presenter: Dr. Nile Stanley, (University of North Florida, United States)
Presentation Type: Oral Presentation (Virtual)
Title: Poetry Therapy (PT): A promising frontier for addiction treatment and resilience building

---

🔬 Presentation Highlights

∙ Innovative Approach: Integrating poetry therapy (PT) into addiction medicine as a compassionate blend of art and science.
∙ Emotional Healing: Facilitates emotional expression, enhances self-awareness, and fosters meaningful insight.
∙ Resilience Building: Long-term data (12 years) from a northeast Florida non-profit demonstrates improvements in emotional awareness, stress reduction, adaptive coping, and resilience.
∙ Relapse Prevention: Supports sustained recovery and reduces risks of incarceration and addiction relapse.
∙ Accessible Tool: Poetry is portable, cost-effective, and can be accessed anytime and anywhere.
∙ Holistic Recovery: Encourages community-building and promotes joy and mental well-being.
∙ Future Outlook: With advancing technology and research, PT can be integrated into mainstream addiction services, offering personalized and holistic recovery pathways.

---

👨‍🏫 About the Speaker

Dr. Nile Stanley is an Associate Professor of Literacy Education and the Arts at the University of North Florida.

∙ 36 years of experience as a reading specialist, poetry educator, artist-in-residence, educational diagnostician, and visiting scholar of narrative psychology in China, Germany, and Vietnam.
∙ Published in the Journal of Poetry Therapy, Reading Psychology, and Language Magazine.
∙ Editorial Board Member of the Journal of Poetry Therapy and past Editor of the Florida Reading Journal.
∙ Founding board member of Hope at Hand, Inc., a non-profit providing art and poetry interventions for underserved youth.
∙ Recognized by AETNA Insurance Company as one of the best non-profit mental health providers in North Florida.

---

🌍 Join the Conference

Event: International Conference on Addiction Medicine, Mental Health and Psychiatry
📅 March 23–25, 2026
📍 Singapore & Online
🌐 Website: https://addiction.miconferences.com/
🧬 Submit Abstract: https://addiction.miconferences.com/abstract-submission
📝 Register Now: https://addiction.miconferences.com/register

Be part of a global platform bringing together experts in addiction medicine, psychiatry, psychology, neuroscience, and mental health innovation. Explore evidence-based practices, emerging therapies, and interdisciplinary approaches shaping the future of recovery care.

#AddictionMedicine #MentalHealth2026 #PsychiatryConference #PoetryTherapy #ResilienceBuilding #AddictionRecovery #BehavioralHealth #SubstanceUseDisorder #HolisticHealing #MentalHealthAwareness #SingaporeConference #VirtualConference #HealthcareInnovation #RecoveryPathways #GlobalHealthConference

🧠 Early-Life Infections & Autism Risk: New Mechanistic Insights

Presenter: Dr. Manuel F. López Aranda (University of Málaga, Spain)
Presentation Type: Oral Presentation (Virtual)
Title: Severe postnatal infections increase autism risk in genetically predisposed males: Mechanistic and therapeutic implications

🔬 Presentation Highlights
∙ Focus: How early-life immune activation interacts with genetic vulnerability to increase autism spectrum disorder (ASD) risk.
∙ Genetic Context: Tuberous Sclerosis Complex (TSC) — a disorder with 40–60% ASD prevalence compared to 1–2% in the general population.
∙ Key Finding (Preclinical Model): Early postnatal immune challenges caused profound social memory deficits and atypical communication specifically in male Tsc2+/- mice.
∙ Mechanism Identified: Dysregulated mTOR-dependent interferon signaling and microglial dysfunction drive sex-specific neurodevelopmental changes.
∙ Therapeutic Breakthrough: Rapamycin treatment both prevented and durably reversed social deficits in genetically vulnerable males.
∙ Genetic Protection: Deletion of interferon receptor IFNAR1 protected against immune-induced behavioral impairments.
∙ Human Data Validation: Analysis of 3+ million medical records revealed that severe early-life infections requiring hospitalization significantly increased ASD risk in boys, but not girls.
∙ Clinical Implications: Highlights potential therapeutic strategies targeting mTOR and interferon pathways in neurodevelopmental and neuropsychiatric disorders.

👨‍🔬 About the Speaker
Dr. Manuel F. López Aranda, Ph.D., is a Distinguished Researcher at the University of Málaga (Spain) under the Beatriz Galindo Program.
∙ Ph.D. in Neuroscience, University of Málaga
∙ Postdoctoral Training at UCLA; served as Assistant Project Scientist
∙ Research Expertise: Neurobiology of learning & memory, microglia, immune activation in ASD and Alzheimer’s disease
∙ Published in leading journals including Science, Nature Reviews Neuroscience, and Science Advances
∙ Internationally recognized for translational research bridging genetics, immunology, and neurodevelopment

🔗 Join the Conference
Event: International Conference on Addiction Medicine, Mental Health and Psychiatry
📅 March 23–25, 2026
📍 Singapore & Online

🌐 Website: https://addiction.miconferences.com/
📝 Submit Abstract: https://addiction.miconferences.com/abstract-submission
🎟 Register: https://addiction.miconferences.com/register

Be part of global discussions on neuroscience, psychiatry, addiction medicine, and innovative therapeutic strategies shaping the future of mental health research.

#AddictionMedicine #MentalHealth #PsychiatryConference #NeuroscienceResearch #AutismResearch #ASD #Neurodevelopment #mTOR #Microglia #Immunology #BrainHealth #TranslationalResearch #GlobalConference #SingaporeConference #MedicalResearch #Psychiatry2026 #NeuroImmunology #ASDResearch #MentalHealthAwareness #MiConferences

Enhancing Access to Addiction Care: A Quality Improvement Approach

🎤 Poster Presentation
Presenter: Dr. Andrew Peh Lai Huat
Affiliation: Changi General Hospital, Singapore
Title: Quality Improvement Project: Enhancing Access to Addiction Services for Patients with Alcohol Use Disorder

---

🔍 Presentation Highlights
• Focus: Addressing the under-detection and under-treatment of alcohol use disorder (AUD) among hospitalized patients.
• Background: AUD prevalence among hospitalized patients ranges from 7.4% to 48%, significantly higher than in the general population, yet referrals to addiction services remain low.
• Objective: To improve referral rates of patients with alcohol use disorder from the Gastroenterology ward to addiction counseling services.
• Methodology:
– Baseline analysis showed only 25 referrals between June 2022 and June 2023.
– Implemented a Plan–Do–Study–Act (PDSA) quality improvement framework.
– Intervention focused on educating junior doctors about the importance of early referral.
• Results:
– Achieved a 32% increase in referral rates from July 2023 to July 2024.
– Total referrals increased to 33 cases post-intervention.
• Conclusion:
– The project demonstrated the effectiveness of interdepartmental collaboration.
– Highlights how targeted education can significantly enhance patient access to addiction services and overall quality of care.

---

👨‍⚕️ About the Speaker
Dr. Andrew Peh Lai Huat is a Senior Consultant in the Department of Psychological Medicine at Changi General Hospital, Singapore.
• Medical degree and Master of Medicine (Psychiatry) from the National University of Singapore.
• Fellow of the Academy of Medicine (Singapore).
• Programme Director of the CGH Assessment and Shared Care Team (ASCAT), a community mental health initiative.
• Clinical Assistant Professor at Duke-NUS Graduate Medical School.
• Senior Clinical Lecturer at NUS Yong Loo Lin School of Medicine.
• Faculty member for the National Psychiatry Residency and SingHealth Family Medicine Residency programs.

---

🔗 Join the Conference
Event: International Conference on Addiction Medicine, Mental Health and Psychiatry
📅 March 23–25, 2026
📍 Singapore & Online
🌐 Website: https://addiction.miconferences.com/
📝 Submit Abstract: https://addiction.miconferences.com/abstract-submission
🧾 Register: https://addiction.miconferences.com/register

#AddictionMedicine #MentalHealthConference #PsychiatryConference #AlcoholUseDisorder
#QualityImprovement #AddictionServices #PublicHealth #CommunityMentalHealth
#PosterPresentation #HealthcareInnovation #SingaporeConference #HybridConference
#MentalHealthCare #AddictionResearch #MIconferences

Enhancing Access to Addiction Services in Hospital Settings

Presenter: Dr. Gabriel Ong Rui Ming
Affiliation: Changi General Hospital, Singapore
Presentation Type: Poster Presentation
Title: Quality Improvement Project:Enhancing Access to Addiction Services for Patients with Alcohol Use Disorder

🔬 Presentation Highlights
∙ Public Health Focus: Alcohol use disorder (AUD) remains significantly under-detected and under-treated among hospitalized patients, despite prevalence rates ranging from 7.4% to 48%.
∙ Clinical Gap Identified: AUD is often overlooked in restructured hospitals, leading to missed opportunities for timely intervention.
∙ Objective: To improve referral rates of patients with alcohol use disorder from the Gastroenterology ward to addiction counselling services.
∙ Methodology: Applied the Plan-Do-Study-Act (PDSA) quality improvement framework.
∙ Baseline Data: Only 25 referrals were made between June 2022 and June 2023 prior to intervention.
∙ Intervention: Targeted education of junior doctors on early identification and referral of patients with potential AUD.
∙ Results: Achieved a 32% increase in referral rates from July 2023 to July 2024 (33 total cases).
∙ Conclusion: Demonstrates the power of interdepartmental collaboration and education in improving addiction care pathways and patient outcomes.

👨‍⚕️ About the Speaker
Dr. Gabriel Ong Rui Ming is a psychiatric doctor with nearly a decade of experience in psychiatry. He is currently practicing at Changi General Hospital, Singapore, with a strong interest in addiction services, hospital psychiatry, and quality improvement initiatives aimed at enhancing patient care.

🔗 Join the Conference
Event: International Conference on Addiction Medicine, Mental Health andPsychiatry
📅 Dates: March 23–25, 2026
📍 Venue: Singapore & Online
🌐 Website: https://addiction.miconferences.com/
🧠 Submit Abstract: https://addiction.miconferences.com/abstract-submission
📝 Register Now: https://addiction.miconferences.com/register

#AddictionMedicine #MentalHealthConference #Psychiatry #AlcoholUseDisorder #QualityImprovement #AddictionServices #HospitalPsychiatry #MentalHealthAwareness #PublicHealth #PsychiatryConference #SingaporeConference #HealthcareInnovation
#MentalHealth2026 #MathewsConferences

Reducing Suicide Risk Through Targeted Pharmacological Strategies

Speaker: Thanompong Sathienluckana
Siam University, Thailand
Session Type: Oral Presentation 
Talk Title: Pharmacological pathways for suicide reduction inpsychiatric patients

🧠 Session Overview
∙ A Critical Global Issue: Suicide remains a leading cause of death globally, with over 700,000 deaths each year and a strong association with psychiatric disorders.
∙ Understanding the Biology: This talk explores key neurobiological mechanisms involved in suicidality, including serotonin dysregulation, neuroinflammation, reduced BDNF, and HPA-axis hyperactivity.
∙ Current Treatment Gaps: Despite advances in psychiatry, no medication is specifically approved for acute suicidal crises—highlighting the need for optimized pharmacotherapy.
∙ Risk-Focused Management: Emphasis on addressing contributory factors such as sleep problems, substance use, medication non-adherence, comorbid illnesses, and psychosocial stressors.
∙ Evidence-Based Medications:
– Clozapine: Proven to lower suicide risk in schizophrenia and schizoaffective disorder, with effects beyond antipsychotic action.
– Lithium: Demonstrates robust anti-suicidal benefits in mood disorders, independent of mood stabilization.
– Ketamine & Intranasal Esketamine: Rapid-onset reduction of depressive symptoms and suicidal ideation in treatment-resistant depression.
– SSRIs: Effective in reducing suicide risk in adults and older populations, with age-specific considerations in younger patients.
∙ Clinical Insight: Highlights the importance of correct dosing, continuity of treatment, and close monitoring to prevent relapse and suicidality.

👨‍⚕️ Meet the Speaker
Thanompong Sathienluckana, PharmD, BCP, serves as Associate Dean for Academic Services at the Faculty of Pharmacy, Siam University, and Academic Chair of the Pharmacotherapy Council of Thailand.
∙ Clinical pharmacist at Somdet Chaopraya Institute of Psychiatry, Bangkok
∙ Specialist in neurologic and psychiatric pharmaceutical care
∙ PharmD graduate from Srinakharinwirot University
∙ Board Certified in Pharmacotherapy

🔗 Attend the Conference
International Conference on Addiction Medicine, Mental Health and Psychiatry
📅 March 23–25, 2026
📍 Singapore & Online
📝 Register Now: https://addiction.miconferences.com/register

#MentalHealth2026 #AddictionMedicineConference #PsychiatryResearch #SuicidePrevention #Psychopharmacology #ClinicalPharmacy #GlobalMentalHealth #EvidenceBasedCare #SingaporeEvents #HealthcareInnovation #MICONFERENCES #MentalHealthProfessionals #RecoveryPathways #SingaporeConference #HybridConference #MIC2026